Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STREAM: ISTEM-01 in Retinitis Pigmentosa
NCT03963154Phase 2Active, not recruiting
- Sponsor
- Centre d'Etude des Cellules Souches
- Start
- Aug 2019
- Primary completion
- Jun 2023
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of ISTEM-01 in retinitis pigmentosa (RP), sponsored by Centre d'Etude des Cellules Souches. Started Aug 2019; status: active, not recruiting.
02
Drugs
ISTEM-01
03
Conditions
retinitis pigmentosa (RP)
Beyond the preview
Go deeper on NCT03963154.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03963154.